Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease

被引:10
作者
Black, P. N. [1 ]
McDonald, C. F. [2 ]
机构
[1] Univ Auckland, Dept Pharmacol & Clin Pharmacol, Auckland 1142, New Zealand
[2] Austin Hosp, Inst Breathing & Sleep, Dept Resp & Sleep Med, Melbourne, Vic 3084, Australia
关键词
PNEUMOCOCCAL POLYSACCHARIDE VACCINE; CONJUGATE VACCINE; DOUBLE-BLIND; PLACEBO; COPD; TIOTROPIUM; REHABILITATION; PREVENTION; MANAGEMENT; HOSPITALIZATION;
D O I
10.1136/pgmj.2008.072439
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Frequent exacerbations of chronic obstructive pulmonary disease (COPD) are associated with impaired quality of life, and hospital admissions for exacerbations account for a large proportion of the expenditure of COPD. An important objective when treating COPD is to reduce the frequency of exacerbations. Studies published in the last few years have increased our knowledge on how to prevent exacerbations, but a number of questions remain unanswered. Tiotropium, inhaled steroids and long-acting inhaled beta agonists reduce the frequency of exacerbations, but further studies are necessary to determine if combining tiotropium with the other inhaled medicines is more effective than using them separately. There is evidence that mucolytics and prophylactic antibiotics reduce exacerbations, but there is uncertainty how these treatments should be used. Both influenza and pneumococcal vaccination are recommended in guidelines, although evidence for the latter remains controversial. Other interventions including oral bacterial extracts and self-management programmes warrant further study.
引用
收藏
页码:141 / 147
页数:7
相关论文
共 49 条
[11]   Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease [J].
Calverley, Peter M. A. ;
Sanchez-Torill, Fernando ;
McIvor, Andrew ;
Teichmann, Peter ;
Bredenbroeker, Dirk ;
Fabbri, Leonardo M. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (02) :154-161
[12]   Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease [J].
Calverley, Peter M. A. ;
Anderson, Julie A. ;
Celli, Bartolome ;
Ferguson, Gary T. ;
Jenkins, Christine ;
Jones, Paul W. ;
Yates, Julie C. ;
Vestbo, Jorgen ;
Calverley, P. M. A. ;
Anderson, J. A. ;
Celli, B. ;
Ferguson, G. T. ;
Jenkins, C. ;
Jones, P. W. ;
Knobil, K. ;
Yates, J. C. ;
Vestbo, J. ;
Cherniack, R. ;
Similowski, T. ;
Cleland, J. ;
Whitehead, A. ;
Wise, R. ;
McGarvey, L. ;
John, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) :775-789
[13]   Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease [J].
Calverley, PM ;
Boonsawat, W ;
Cseke, Z ;
Zhong, N ;
Peterson, S ;
Olsson, H .
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (06) :912-919
[14]   Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease [J].
Collet, JP ;
Shapiro, S ;
Ernst, P ;
Renzi, P ;
Ducruet, T ;
Robinson, A ;
Gauthier, G ;
Beaupre, A ;
Gregoire, P ;
Jacquemin, P ;
Plante, F ;
Lachance, Y ;
Provost, G ;
Hernandez, P ;
JeanFrancois, R ;
Charbonneau ;
Inhaber, N ;
Braidy, J ;
Jeanneret, A ;
Bolduc, P ;
Leblanc, PP ;
Olivenstein, R ;
Mannix, S ;
Chrysler, B ;
Wolkove, N ;
Kreisman, H ;
Frank ;
Fox, J ;
Colman, N ;
Gruber, J ;
Zidulka ;
Gursahaney, A ;
Matouk ;
Eidelman, D ;
Julien, M ;
Malo, J ;
Dandurand, R ;
Skamene, E ;
Suissa, S ;
Choi, S ;
Martin, J ;
Dankoff, G ;
Enjalbert, M ;
Lauener, PA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (06) :1719-1724
[15]   Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial [J].
Cutts, FT ;
Zaman, SMA ;
Enwere, G ;
Jaffar, S ;
Levine, OS ;
Okoko, JB ;
Oluwalana, C ;
Vaughan, A ;
Obaro, SK ;
Leach, A ;
McAdam, KP ;
Biney, E ;
Saaka, M ;
Onwuchekwa, U ;
Yallop, F ;
Pierce, NF ;
Greenwood, BM ;
Adegbola, RA .
LANCET, 2005, 365 (9465) :1139-1146
[16]   Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS):: a randomised placebo-controlled trial [J].
Decramer, M ;
Rutten-van Mölken, M ;
Dekhuijzen, PNR ;
Troosters, T ;
van Herwaarden, C ;
Pellegrino, R ;
van Schayck, CPO ;
Olivieri, D ;
Del Donno, M ;
De Backer, W ;
Lankhorst, I ;
Ardia, A .
LANCET, 2005, 365 (9470) :1552-1560
[17]   Self-management education for patients with chronic obstructive pulmonary disease [J].
Effing, T. ;
Monninkhof, E. M. ;
van der Valk, P. D. L. P. M. ;
van der Palen, J. ;
van Herwaarden, C. L. A. ;
Partidge, M. R. ;
Walters, E. H. ;
Zielhuis, G. A. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (04)
[18]   Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study [J].
Godtfredsen, NS ;
Vestbo, J ;
Osler, M ;
Prescott, E .
THORAX, 2002, 57 (11) :967-972
[19]  
GRANGER R, 2006, COCHRANE DB SYST REV, V4
[20]   Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial [J].
Griffiths, TL ;
Burr, ML ;
Campbell, IA ;
Lewis-Jenkins, V ;
Mullins, J ;
Shiels, K ;
Turner-Lawlor, PJ ;
Payne, N ;
Newcombe, RG ;
Lonescu, AA ;
Thomas, J ;
Tunbridge, J .
LANCET, 2000, 355 (9201) :362-368